Last updated 2026-07-22
- Acquired by Intelicanna Ltd., Mar 2019
- Raised Undisclosed Round, Jan 2020
Total raised
—
Last: Undisclosed Round 2017-01
Stage
Mature
Founded
2014
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Alvit LCS Pharma was founded in 2014 with the goal of researching and developing cannabis-based pharmaceutical products. The company has developed a broad line of pharma-grade cannabis products including tablets, sprays, and suppositories, several of which have completed or been approved for clinical trials in Israel. Alvit controls the entire lifecycle of the cannabis drug development process, from EU-GMP cultivation of proprietary cannabis clones to advanced drug delivery and global commercialization initiatives. They also have international initiatives in Malta and Germany for cultivation, manufacturing, marketing, and distribution.
Funding history · 1 round · — total
2020-01
Undisclosed Round
Undisclosed
Headcount over time
From 7 (2018-11) to 8 (2026-07) · +1 (+14%) · 25 points · source: Finder history + radar grounding
Q&A
- What is Alvit LCS Pharma's primary focus?
- Alvit LCS Pharma is a vertically integrated medical cannabis research and development company specializing in pharmaceutical-grade cannabis product development and drug-delivery technologies.
- What types of products does Alvit LCS Pharma develop?
- Alvit LCS Pharma's products include various types of tablets, sprays, and suppositories, focusing on pharmaceutical-grade cannabis.
- When was Alvit LCS Pharma founded?
- Alvit LCS Pharma was founded in April 2014.
- How many employees does Alvit LCS Pharma have?
- Alvit LCS Pharma has 1-10 employees.
- Has Alvit LCS Pharma participated in any funding rounds?
- Alvit LCS Pharma had a funding round in January 2017 with Oded Zucker as an investor.
- What was a significant corporate development for Alvit LCS Pharma in late 2018?
- In November 2018, Alvit LCS Pharma announced the merger of its cannabis growing activity into Intelicann, a cannabis cultivation facility in Israel that is publicly traded on the Tel Aviv Stock Exchange.
- Who are the co-founders of Alvit LCS Pharma?
- The co-founders of Alvit LCS Pharma are Itschak Lamensdorf, Nachshol Cohen (Co-founder & CSO), and Yoram Sela (Co-founder & VP R&D).
- What is the current stage of Alvit LCS Pharma?
- Alvit LCS Pharma is currently in the Mature stage.
Team · 3
Itschak Lamensdorf
Founder · Co-Founder
Nachshol Cohen
Founder · Co-Founder
Yoram Sela
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
Materials & SubstancesRaw Materials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
medical-cannabispharmaceuticalsdrug-deliverypatientscannabis
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | alvitpharma.com/ |
|---|---|
| linkedin.com/company/11741297 | |
| facebook.com/Alvit-LCS-Pharma-540309976489069 |
Identifiers & details
| Founded | 2014 |
|---|---|
| Employees (exact) | 6 |
Acquisitions & public offerings
Acquired by Intelicanna Ltd. 2019-03
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | alvitpharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515072056 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-04-24 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2022 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | קורא הדורות 26 ירושלים |